scholarly journals The Perceptions Of Traditional Healers Of Cervical Cancer Care At Ga Mothapo Village In Limpopo Province

2008 ◽  
Vol 7 (1) ◽  
Author(s):  
SM Mokgadi ◽  
MM Fhumulani
Keyword(s):  
Cervical Cancer ◽  
Cancer Care ◽  
Traditional Healers ◽  
Limpopo Province

scholarly journals Erectile dysfunction: Definition and materia medica of Bapedi traditional healers in Limpopo province, South Africa

2015 ◽  
Vol 9 (3) ◽  
pp. 71-77 ◽  
Author(s):  
Johannes Christoffel Erasmus Lourens ◽  
Johannes Potgieter Marthienus ◽  
Silas Semenya Sebua
Keyword(s):  
South Africa ◽  
Erectile Dysfunction ◽  
Traditional Healers ◽  
Limpopo Province ◽  
Materia Medica

scholarly journals Plants Used by Bapedi Traditional Healers to Treat Asthma and Related Symptoms in Limpopo Province, South Africa

2018 ◽  
Vol 2018 ◽  
pp. 1-33 ◽  
Author(s):  
Sebua Silas Semenya ◽  
Alfred Maroyi
Keyword(s):  
South Africa ◽  
South African ◽  
Study Finding ◽  
Traditional Healers ◽  
Limpopo Province ◽  
Herbal Remedies ◽  
Face To Face ◽  
Sclerocarya Birrea ◽  
Time In Literature ◽  
Herbal Therapies

To the best of our knowledge there are presently no ethnobotanical surveys focusing on the utilisation of herbal remedies for asthma in South Africa. The present study is therefore an attempt to fill this gap in knowledge. A total of 140 Bapedi traditional healers (THs) practicing in the Capricorn, Sekhukhune, and Waterberg districts of the Limpopo Province (South Africa) were queried using semistructured questionnaires, supplemented by field observations during face-to-face interview. A total of 104 medicinal plant species (92 indigenous and 12 exotics) belonging to 92 genera, distributed across 54 botanical families, mostly the Asteraceae and Fabaceae (18.5%, for each) as well as Malvaceae (12.9%), were used as antiasthmatics and related symptoms by these THs. Most of the plants were trees and herbs (37.5%, for each), with root (57%), leaf (15.8%), and bark (7.5%), respectively, being the saliently used parts for preparation of remedies.Clerodendrum ternatum,Cryptocarya transvaalensis,Lasiosiphon caffer,Enicostema axillare,Mimusops obovata,Sclerocarya birrea, andStylochaeton natalensiswere widely used and valued by all THs across the surveyed districts. Furthermore, these taxa also scored both the highest use value and fidelity level indexes as asthma therapies. Overall, the larger number of species documented in the present study is recorded for the first time in literature as asthma and/or related symptoms remedies. Our study finding generally contributes towards an establishment of South African database of herbal therapies used traditionally against these conditions.

Mapping the Cervical Cancer Care Cascade in Johannesburg, South Africa: Baseline Cohort Description [36B]

2019 ◽  
Vol 133 (1) ◽  
pp. 29S-30S
Author(s):  
Austin M. Oberlin ◽  
Masangu Mulongo ◽  
Sibongile Ramotshela ◽  
Tafadzwa Pasipamire ◽  
Carla Joan Chibwesha
Keyword(s):  
South Africa ◽  
Cervical Cancer ◽  
Cancer Care ◽  
Care Cascade

scholarly journals Amate: A Mobile Application To Improve Access To Early Breast And Cervical Cancer Detection

2018 ◽  
Vol 4 (Supplement 3) ◽  
pp. 26s-26s
Author(s):  
Carlos Munoz-Zuluaga ◽  
Armando Sardi ◽  
Mavalynne Orozco-Urdaneta ◽  
Luis Gabriel Parra-Lara ◽  
Andres Perez ◽  
...  
Keyword(s):  
Health Care ◽  
Cervical Cancer ◽  
Risk Factor ◽  
Early Detection ◽  
Cancer Detection ◽  
Cancer Care ◽  
Early Cancer ◽  
Early Cancer Detection ◽  
Screening Tests ◽  
Breast And Cervical Cancer

Purpose For Colombian women, breast and cervical cancer are the leading causes of mortality, despite being potentially curable through early detection and timely treatment. Tedious administrative processes and a lack of cancer screening education and awareness hinders early detection. Mobile applications (mApps) have permeated all levels of society and are potential tools by which to deliver personalized information and identify high-risk patients in need of screening tests thereby improving early cancer detection. The aim of this work is to create a free mApp that educates and guides patients to the national screening programs for breast and cervical cancer. Methods An mApp Amate was advertised to women (age ≥ 14 years) in the waiting rooms of a health care facility of a community hospital during a period of 9 months. Amate used educational, evaluative, and risk factor questions to measure the population’s knowledge of breast and cervical cancer. Each question was followed by an explanation. Correct answers yielded points that were redeemable for cellular data. Risk assessment questions identified women who required screening who were subsequently contacted by a health care provider and enrolled in the national cancer care program. Results A total of 4,553 women were contacted from August 2017 to May 2018. Of this group, 830 downloaded Amate and answered all of the questions. On the basis of the risk factor questions, 16% of patients (n = 131) were identified as being at risk for breast and/or cervical cancer and needed to be enrolled in the national screening program. Thus far, 24% of patients (n = 32) have successfully completed their recommended screening tests—mammogram, Papanicolau smear, or both. We also identified specific barriers to enrolling patients in these programs, including an unwillingness to be enrolled, limited available appointments at health care centers, and denied access as a result of health care coverage. Conclusion Amate is a low-cost, accessible tool that identifies women who are at risk for breast and cervical cancer and detects access barriers to early cancer detection. Administrative obstacles still exist and must be addressed to improve early cancer detection and screening. Amate has the potential to reach people from rural areas of Colombia and other underserved countries. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc . Armando Sardi Stock or Other Ownership: Celgene, Johnson & Johnson Mavalynne Orozco-Urdaneta Employment: Partners For Cancer Care And Prevention Foundation, Stamina-in-Action Stock or Other Ownership: Celgene, Johnson & Johnson Luis Gabriel Parra-Lara Research Funding: Merk & Co

scholarly journals The Care Pathway Delays of Cervical Cancer Patient in Morocco

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Hind Mimouni ◽  
Khalid Hassouni ◽  
Boujemaa El Marnissi ◽  
Bouchra Haddou Rahou ◽  
Leila Alaoui ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Health System ◽  
Cancer Care ◽  
Care Pathway ◽  
Diagnostic Delay ◽  
Patient Delay ◽  
University Hospital ◽  
Cervical Cancer Patient ◽  
Diagnosis Delay ◽  
Time Intervals

Introduction. The aim of this study is to document time intervals in cervical cancer care pathways, from symptom onset to disease detection and start of treatment, and evaluate how clinical, sociodemographic, and treatment factors influence delays throughout a patient’s clinical pathway. Methods. A retrospective study was conducted at the FEZ Oncology Hospital of the Hassan II University Hospital Center in Morocco. Results. 190 medical records of cervical cancer patients were collected. The dominant age group was 35–44, the median patient delay (PD) was 6 days, the median healthcare provider’s delay (HCP) was 21 days, the median referral delay (RD) was 17 days, the median diagnostic delay (DD) was 9.5 days, the median total diagnostic delay (TDD) was 16 days, the median treatment delay (TD) was 67 days, and the median health system interval (HSI) was 92 days. Multivariate analysis revealed that age was associated with the patient delay, the healthcare provider’s delay, the diagnosis delay, and the health system interval. The diagnosis year (the year in which the patient was diagnosed (either before 2012 or during 2012 as well as the other study years (from 2013 to 2017))), all investigations done prior to admission to the oncology hospital, and the age of first sexual activity were significantly associated with healthcare provider’s delay. Conclusion. The integration of a model and standard care pathway into the Moroccan health system is essential in order to unify cervical cancer care in the country.

Sign in / Sign up

Export Citation Format

Share Document